Patents Assigned to CellAxia Inc.
  • Cell-containing pharmaceutical composition
    Patent number: 12460182
    Abstract: A pharmaceutical composition containing a cell population with enriched M2 macrophage and a pharmaceutically acceptable carrier is provided. The composition is not trapped in the lungs when administered systemically, and accumulates at a disorder/inflammation site. Therefore, the pharmaceutical composition of the present invention is useful as an anti-inflammatory pharmaceutical composition.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: November 4, 2025
    Assignee: CellAxia Inc.
    Inventors: Takayuki Asahara, Amankeldi A. Salybekov, Makoto Seki
  • CELL-CONTAINING PHARMACEUTICAL COMPOSITION
    Publication number: 20220218744
    Abstract: A pharmaceutical composition containing a cell population with enriched M2 macrophage and a pharmaceutically acceptable carrier is provided. The composition is not trapped in the lungs when administered systemically, and accumulates at a disorder/inflammation site. Therefore, the pharmaceutical composition of the present invention is useful as an anti-inflammatory pharmaceutical composition.
    Type: Application
    Filed: August 19, 2019
    Publication date: July 14, 2022
    Applicant: CellAxia Inc.
    Inventors: Takayuki ASAHARA, Amankeldi A. SALYBEKOV, Makoto SEKI